Steven St. Peter
2013
In 2013, Steven St. Peter earned a total compensation of $1.2M as President and CEO at Aratana Therapeutics, a 228% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,625 |
|---|---|
| Option Awards | $553,040 |
| Salary | $425,000 |
| Other | $13,725 |
| Total | $1,172,390 |
Peter received $553K in option awards, accounting for 47% of the total pay in 2013.
Peter also received $180.6K in non-equity incentive plan, $425K in salary and $13.7K in other compensation.
Rankings
In 2013, Steven St. Peter's compensation ranked 5,941st out of 12,286 executives tracked by ExecPay. In other words, Peter earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,941 out of 12,286 | 52nd |
Division Manufacturing | 2,062 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 603 out of 1,462 | 59th |
Industry group Drugs | 433 out of 1,156 | 63rd |
Industry Pharmaceutical Preparations | 348 out of 890 | 61st |
Source: SEC filing on April 28, 2015.
Peter's colleagues
We found four more compensation records of executives who worked with Steven St. Peter at Aratana Therapeutics in 2013.